Mayo Clinic Laboratory and pathology research roundup: January 11 - Insights
This week’s research roundup features: The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
February 2023 - Endocrine Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Endocrine Pathology.
A Test in Focus Archives - Page 10 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Learn more about our comprehensive menu of COVID-19 molecular, serology, and related testing.
Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.
Comprehensive drug urine profiles - Insights
Able to detect 22 drug classes, our comprehensive addiction medicine profile can help identify polysubstance use disorder as well as assess and manage patients at risk for substance use disorder.
Therapeutic drug monitoring - Insights
Learn more about Mayo Clinic Laboratories’ clinically driven approach to therapeutic drug monitoring.
Hereditary causes of kidney stones - Insights
Learn about our kidney stone panel, which assesses 72 genes associated with inherited conditions that can lead to stone development.
Learn how the pulmonary pathology section at Mayo Clinic Laboratories can provide second-opinion consultations on a broad range of neoplastic and nonneoplastic thoracic cases, including primary ciliary dyskinesia.
CPT codes and LOINC update: January 2023 - Insights
This page includes updates posted to the site during the month of January.